ALIGN TECHNOLOGY INC
Business
ALIGN TECHNOLOGY INC is a global medical device company that designs, manufactures and markets digital orthodontic and restorative solutions, including Invisalign clear aligners, Vivera retainers, iTero intraoral scanners and exocad CAD/CAM software. Its primary offerings include doctor-prescribed Invisalign clear aligner treatment and retainers, intraoral scanning systems and imaging, CAD/CAM software, digital treatment planning tools and complementary accessories and services. The company operates through two segments: Clear Aligner and Systems and Services (Imaging Systems and CAD/CAM). It sells primarily to orthodontists, general dentists, dental laboratories and dental support organizations worldwide via a direct sales force, distributors, online platforms and retail channels.
Summary from filing dated 2025-02-28
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net revenues | 4,035 | 3,999 | 3,862 | 3,735 | 3,953 | |
| Cost of net revenues | 1,324 | 1,200 | 1,155 | 1,101 | 1,017 | |
| Gross profit | 2,711 | 2,799 | 2,707 | 2,634 | 2,935 | |
| Selling, general and administrative | 1,756 | 1,763 | 1,703 | 1,674 | 1,709 | |
| Research and development | 370 | 364 | 347 | 305 | 250 | |
| Restructuring and other charges | 35 | 33 | 13 | 11 | — | |
| Legal settlement loss | 4 | 31 | 0 | 0 | 0 | |
| Total operating expenses | 2,165 | 2,192 | 2,064 | 1,991 | 1,959 | |
| Income from operations | 546 | 608 | 643 | 643 | 976 | |
| Interest income | 16 | 20 | 17 | 5 | 3 | |
| Other income (expense), net | 23 | −19 | −19 | −49 | 33 | |
| Total interest income and other income (expense), net | 40 | 1 | −2 | −44 | 36 | |
| Net income before provision for income taxes | 585 | 609 | 641 | 599 | 1,012 | |
| Income Tax expense | 175 | 188 | 196 | 237 | 240 | |
| Net income | 410 | 421 | 445 | 362 | 772 | |
| Net income per share, basic (usd per share) | 5.66 | 5.63 | 5.82 | 4.62 | 9.78 | |
| Diluted (usd per share) | 5.65 | 5.62 | 5.81 | 4.61 | 9.69 | |
| Basic (shares) | 73 | 75 | 76 | 78 | 79 | |
| Diluted (shares) | 73 | 75 | 77 | 78 | 80 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 1,095 | 1,044 | 937 | 942 | 1,099 | |
| Accounts receivable, net of allowance for doubtful accounts of $34,213 and $19,131, respectively | 1,102 | 996 | 903 | 860 | 897 | |
| Inventories | 226 | 254 | 297 | 339 | 230 | |
| Prepaid expenses and other current assets | 166 | 199 | 274 | 226 | 195 | |
| Assets held for sale | 28 | 0 | — | — | — | |
| Total current assets | 2,617 | 2,492 | 2,447 | 2,424 | 2,494 | |
| Property, plant and equipment, net | 1,131 | 1,271 | 1,291 | 1,232 | 1,082 | |
| Operating lease right-of-use assets, net | 108 | 113 | 118 | 119 | 121 | |
| Goodwill | 492 | 443 | 420 | 408 | 419 | |
| Intangible assets, net | 94 | 103 | 82 | 96 | 110 | |
| Deferred tax assets | 1,514 | 1,557 | 1,590 | 1,572 | 1,534 | |
| Other assets | 278 | 234 | 129 | 56 | 58 | |
| Total assets | 6,234 | 6,215 | 6,084 | 5,948 | 5,942 | |
| Accounts payable | 121 | 109 | 113 | 128 | 164 | |
| Accrued liabilities | 537 | 598 | 526 | 454 | 607 | |
| Deferred revenues | 1,262 | 1,331 | 1,428 | 1,344 | 1,153 | |
| Total current liabilities | 1,920 | 2,038 | 2,067 | 1,926 | 1,924 | |
| Income tax payable | 68 | 96 | 117 | 124 | 118 | |
| Operating lease liabilities | 83 | 88 | 97 | 100 | 103 | |
| Other long-term liabilities | 114 | 140 | 173 | 196 | 175 | |
| Total liabilities | 2,185 | 2,363 | 2,453 | 2,347 | 2,319 | |
| Commitments and contingencies (Notes 8 and 9) | — | — | — | — | — | |
| Preferred stock, $0.0001 par value (5,000 shares authorized; none issued) | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.0001 par value (200,000 shares authorized; 71,364 and 73,849 issued and outstanding, respectively) | 7,000 | 7,000 | 7,000 | 8,000 | 8,000 | |
| Additional paid-in capital | 1,510 | 1,362 | 1,162 | 1,045 | 999 | |
| Accumulated other comprehensive income (loss), net | 75 | 6 | 21 | −10 | 4 | |
| Retained earnings | 2,464 | 2,484 | 2,447 | 2,567 | 2,619 | |
| Total stockholders equity | 4,049 | 3,852 | 3,630 | 3,601 | 3,623 | |
| Total liabilities and stockholders equity | 6,234 | 6,215 | 6,084 | 5,948 | 5,942 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Deferred taxes | 33 | 26 | −19 | −39 | 15 | |
| Depreciation and amortization | 237 | 145 | 142 | 126 | 109 | |
| Stock-based compensation | 186 | 174 | 154 | 133 | 114 | |
| Non-cash operating lease cost | 40 | 38 | 33 | 31 | 27 | |
| Impairment loss on Assets held for sale | 23 | 0 | 0 | — | — | |
| Impairment and fair value adjustments for equity investments | −18 | −6 | 5 | 0 | — | |
| Other non-cash operating activities | 38 | 12 | 33 | 41 | 24 | |
| Accounts receivable | −140 | −153 | −105 | 22 | −262 | |
| Inventories | 808,000 | 25 | 30 | −130 | −112 | |
| Prepaid expenses and other assets | 13 | 68 | −51 | −66 | −125 | |
| Accounts payable | 5 | −843,000 | −8 | −37 | 20 | |
| Accrued and other long-term liabilities | −96 | 90 | 46 | −122 | 159 | |
| Long-term income tax payable | −28 | −20 | −8 | 6 | 12 | |
| Deferred revenues | −112 | −80 | 87 | 242 | 463 | |
| Net cash provided by operating activities | 593 | 738 | 786 | 569 | 1,173 | |
| Acquisitions, net of cash acquired | 0 | −77 | 0 | −12 | −8 | |
| Purchase of property, plant and equipment | −102 | −116 | −178 | −292 | −401 | |
| Purchase of marketable securities | 0 | 0 | −3 | −28 | −201 | |
| Proceeds from maturities of marketable securities | 0 | 26 | 55 | 24 | 498,000 | |
| Proceeds from sales of marketable securities | 0 | 18 | 6 | 97 | 3 | |
| Purchase of equity investments | −10 | −106 | −77 | 0 | 0 | |
| Other investing activities | 0 | 235,000 | 278,000 | −2 | −5 | |
| Net cash used in investing activities | −112 | −255 | −196 | −213 | −563 | |
| Proceeds from issuance of common stock | 22 | 25 | 27 | 26 | 26 | |
| Common stock repurchases, net of excise tax | −466 | −353 | −592 | −435 | −375 | |
| Activity for equity forward contracts related to accelerated stock repurchase agreements, net | 0 | 0 | −10 | −40 | 0 | |
| Payroll taxes paid upon the vesting of equity awards | −20 | −28 | −23 | −53 | −109 | |
| Net cash used in financing activities | −465 | −356 | −598 | −502 | −458 | |
| Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash | 35 | −21 | 5 | −12 | −12 | |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | 51 | 106 | −4 | −158 | 139 |